MedTrace Logo

Evaluation Of The Effect Of Morphological Structure On Dilatational Tracheostomy Interference Location And Complications

NCT05845775 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 104

Last updated 2024-03-19

No results posted yet for this study

Summary

In recent years, percutaneous dilatational tracheostomy has become a frequently performed procedure in intensive care units. However, tracheostomy procedure has risks of complications of varying severity, such as bleeding, subcutaneous emphysema, posterior tracheal wall damage, tracheal stenosis, infection, and fistula in the early and late periods. It is important to determine the anatomical position for tracheal puncture in reducing the risk of complications. It is not always possible to determine the optimal anatomical position for tracheal puncture in patients in the intensive care unit due to reasons such as obesity patient positioning difficulties and tracheal deviation. In this stuy, we have purpose to evaluate the effect of the morphological structure of patients on the dilatational tracheostomy interference location and complications in the percutaneous dilatational tracheostomy procedure (using anatomical landmarks) performed with the forceps dilatation technique, using fiberoptic bronchoscopy and ultrasonography.

Conditions

  • Tracheostomy Complication

Interventions

PROCEDURE

Percutaneous dilatational tracheostomy

The percutaneous dilatational tracheostomy procedure will be performed via fiberoptic bronchoscopy

DEVICE

Bronchoscopy

Fiberoptic bronchoscopy

DEVICE

ultrasonography

ultrasonography

DIAGNOSTIC_TEST

Bronchoscopy application

Fiberoptic bronchoscopy application

DIAGNOSTIC_TEST

Ultrasound examination

Ultrasound examination

Sponsors & Collaborators

  • Melike Cengiz

    lead OTHER

Principal Investigators

  • Esin Bulut, MD · Akdeniz University School of Medicine, Department of Anesthesiology and Intensive Care, Turkey

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-04-30
Primary Completion
2024-02-02
Completion
2024-02-02

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05845775 on ClinicalTrials.gov